...
首页> 外文期刊>Cureus. >Olmesartan-induced Enteropathy: A Rare Side Effect of a Common Medication
【24h】

Olmesartan-induced Enteropathy: A Rare Side Effect of a Common Medication

机译:Olmesartan诱导的肠病:常见用药的罕见副作用

获取原文
           

摘要

Ischemic heart disease and stroke are the leading causes of mortality worldwide according to the World Health Organization.?Hypertension is a major factor in the development of these diseases. Olmesartan is an angiotensin II receptor blocker (ARB) indicated in the treatment of hypertension. There are several case reports describing sprue-like enteropathy caused by olmesartan. We report on a 72-year-old patient referred to our hospital for work-up of chronic diarrhoea, vomiting and weight-loss, and villous atrophy on intestinal biopsy. The patient’s symptoms abated upon cessation of olmesartan. This case illustrates the need for a thorough medication history and regular review during work-up. We hope it will add to the current understanding of this rare phenomenon.
机译:缺血性心脏病和中风是世界卫生组织的全世界死亡的主要原因.Hypertension是这些疾病发展的主要因素。 Olmesartan是一种血管紧张素II受体阻滞剂(ARB),用于治疗高血压。有几个案例报告描述了由Olmesartan引起的春天肠病。我们报告了一名72岁的患者,提到我们医院的慢性腹泻,呕吐和减肥,以及肠道活检的绒毛萎缩。患者在奥米沙坦停止时减少了症状。这种情况说明了在处理期间需要彻底的药物历史和常规审查。我们希望它将增加目前对这种罕见现象的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号